A First-in-Human SAD/MAD Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ENC1018 in Healthy Adult Subjects
Clinical trial NCT06224400 · COMPLETED
Trial details
- NCT number
- NCT06224400
- Sponsor
- EnnovaBio Australia Pharmaceuticals Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-05
- Primary completion
- 2024-09-09
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.